Synthesis and secretion of tumour necrosis factor-α by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts

Immunology Letters

Volumn 58, Issue 3, 1997, Pages 139-147

  Abordo, Evelyn A ^a   Thornalley, Paul J ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

Advanced glycation end product; Chemotaxis; Diabetic complications; Glycation; Methylglyoxal; THP 1 cells; Tumour necrosis factor (TNF )

Indexed keywords

ALBUMIN; GLUCOSE; METHYLGLYOXAL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CONCENTRATION RESPONSE; GLYCATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ARGININE; CHEMOTAXIS, LEUKOCYTE; CYSTINE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MONOCYTES; PYRUVALDEHYDE; SERUM ALBUMIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030844059     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(97)00080-1     Document Type: Article

References (52)

1. D.R. McCance, D.G. Dyer, J.A. Dunn, K.E. Baiue, S.R. Thorpe, J.W. Baynes, T.J. Lyons, Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus, J. Clin. Invest. 91 (1993) 2470-2478.
2. T.J. Lyons, G. Silvestri, J.A. Dunn, D.G. Dyer, J.W. Baynes, Role of glycation in modification of lens crystalline in diabetic and nondiabetic senile cataracts, Diabetes 40 (1991) 1010-1015.
3. H. Vlassara, H. Fuh, Z. Makita, S. Krungkrai, A. Cerami, R. Bucala, Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications, Proc. Natl. Acad. Sci. USA 89 (1992) 12043-12047.
4. M.P. Vitek, K. Bhattyacharya, J.M. Glendening, E. Stopa, H. Vlassara, R. Bucala, K. Manogue, A. Cerami, Advanced glycation end products contribute to amyloidosis in Alzheimer disease, Proc. Natl. Acad. Sci. USA 91 (1994) 4766-4770.
5. 2-Microglobulin modified with advanced glycation end products is a major component of haemodialysis-associated amyloidosis, J. Clin. Invest. 92 (1993) 1242-1252.
6. A.C. McLellan, P.J. Thornalley, J. Benn, P.H. Sönksen, The glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications, Clin. Sci. 87 (1994) 21-29.
7. P.J. Thornalley, Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress, Endocrinol. Metab. 3 (1996) 149-166.
8. α-acetyl-lysine, and bovine serum albumin, J. Biol. Chem. 269 (1994) 32299-32305.
9. ∈-(carboxyethyl)lysine in tissue protein: evidence for formation of methylglyoxal adducts in proteins in vivo, Diabetes (Abstract) 45 (1996) 266A.
10. R.H. Nagaraj, I.N. Shipanova, F.M. Faust, Protein cross-linking by the Maillard reaction - Isolation, characterization, and in-vivo detection of a lysine-lysine cross-link derived from methyl-glyoxal, J. Biol. Chem. 271 (1996) 19238-19245.
11. M.E. Westwood, A.C. McLellan, P.J. Thornalley, Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation endproduct-modified serum albumin at the advanced glycation endproduct receptor, J. Biol. Chem. 269 (1994) 32293-32298.
12. S.M. Shaw, M.J.C. Crabbe, Non-specific binding of advanced glycosylation endproducts to macrophages outweighs specific receptor-mediated interactions, Biochem. J. 304 (1994) 121-129.
13. A. Lapolla, D. Fedele, R. Seraglia, S. Catinella, L. Baldo, R. Aronica, P. Traldi, A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects, Diabetologia 38 (1995) 1076-1081.
14. M.E. Westwood, O.K. Argirov, E.A. Abordo, P.J. Thornalley, Methylglyoxal-modified arginine residues - a signal for receptormediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta (1997) in press.
15. M.E. Westwood, P.J. Thornalley, Induction of synthesis and secretion of interleukin Iβ in the human monocytic leukaemia THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts, Immunol. Lett. 50 (1996) 17-21.
16. E.A. Abordo, M.E. Westwood, P.J. Thornalley, Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts, Immunol. Lett. 53 (1996) 7-13.
17. E. Abordo, O.K. Argirov, P.J. Thornalley, Human serum albumin minimally-modified by methylglyoxal but not by glucose-derived advanced glycation endproducts induced the synthesis and secretion of tumour necrosis factor-α (TNFα) by human monocytic THP-1 cells in vitro, Diabetes (Abstract) 45 (1996) 129A.
18. A.C. McLellan, P.J. Thornalley, Synthesis and chromatography of 1,2-diamino-4,5-dimethoxybenzene, 6,7-dimethoxy-2-methyl-quinoxaline and 6,7-dimethoxy-2,3-dimethylquinoxaline for use in a liquid chrmatographic fluorimetric assay of methylglyoxal, Anal. Chim. Acta 263 (1992) 137-142.
19. A.C. McLellan, S.A. Phillips, P.J. Thornalley, The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene, Anal. Biochem. 206 (1992) 17-23.
20. M.E. Westwood, P.J. Thornalley, Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation end-product-modified serum albumins, J. Prot. Chem. 14 (1995) 359-372.
21. J.M. Wang, D.W. McVicar, J.J. Oppenheim, D.J. Kelvin, Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic chemokines, J. Exp. Med. 177 (1993) 699-705.
22. Y. Tanabe, N. Kitahara-Tanabe, D. Mizuno, G.-I. Soma, Enhanced production of tumour necrosis factor-α (TNF α) by its precursor on the cell surface of primed THP-1 cells, Cytokine 6 (1994) 337-348.
23. K.M. Mohler, P.R. Sleath, J.N. Fitzner, D.P. Ceretti, M. Alderson, S.S. Kerwar, D.S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, S.R. Kronheim, M. Petersen, M. Gerhart, C.J. Kozlosky, C.J. March, R.A. Black, Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing, Nature 370 (1994) 218-220.
24. M. Kriegler, C. Perez, K. DeFay, I. Albert, S.D. Lu, A novel form of TNF/cachetin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell 53 (1988) 45-53.
25. S. Fukuse, T. Maeda, D.R. Webb, B.H. Devens, A 69-kDa membrane protein associated with lipopolysaccharide (LPS)-induced signal transduction in the human monocytic cell-line THP-1, Cell. Immunol. 164 (1995) 248-254.
26. R. Datta, K. Imamura, S.J. Goldman, A.C. Dianoux, D.W. Kufe, M.L. Sherman, Functional expression of the macrophage colony-stimulating factor receptor in human THP-1 monocytic leukemia cells, Blood 79 (1992) 904-912.
27. E.S. Kimball, E. Kovacs, M.C. Clark, C.R. Schneider, Activation of cytokine production and adhesion molecule expression in THP-1 myelomonocytic cells by macrophage colony-stimulating factor in combination with interferon-gamma, J. Leukocyte Biol. 58 (1995) 585-594.
28. H.W. Duan, Z.G. Li, T. Mazzone, Tumour-necrosis-factor-alpha modulates monocyte/macrophage apoprotein-E gene expression, J. Clin. Invest. 96 (1995) 915-922.
29. R. Pai, B. Bassa, M.A. Kirschenbaum, V.S. Kamanna, TNF-α stimulates monocyte adhesion to glomerular mesangial cells, J. Immunol. 156 (1996) 2571-2579.
30. T. Couffinhal, C. Duplaa, L. Labat, J.M.D. Lamaziere, C. Moreau, O. Printseva, J. Bonnet, Tumour-necrosis-factor-alpha stimulates ICAM-1 expression in human vascular smoothmuscle cells, Arteriosclerosis Thrombosis 13 (1993) 407-414.
31. M.S. Bajaj, R.R. Kew, R.O. Webster, T.M. Hyers, Priming of human neutrophil functions by tumour-necrosis-factor - enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe, Inflammation 16 (1992) 241-250.
32. R. Moser, B. Scheiffenbaum, P. Groscurth, J. Fehr, Interleukin-1 and tumour necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage, J. Clin. Invest. 83 (1989) 444-445.
33. M. Yoshizumi, S. Kourembanas, D.H. Temizer, R.P. Cambria, T. Quertermous, M.E. Lee, Tumour-necrosis-factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular-endothelial cells, J. Biol. Chem. 267 (1992) 9467-9469.
34. S.K. Clinton, R. Underwood, I. Rayes, M.L. Sherman, D.W. Kube, P. Libby, Macrophage colony-stimulating factor gene-expression in vascular cells and in experimental and human atherosclerosis, Am. J. Pathol. 140 (1992) 301-316.
35. R.M. Stricter, R. Wiggins, S.H. Phan, Monocyte chemtoactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells, Biochem. Biophys. Res. Commun. 162 (1996) 694-700.
36. H.G. Rus, F. Niculescu, R. Vlaicu, Tumour-necrosis-factor-alpha in human arterial-wall with atherosclerosis, Atherosclerosis 89 (1991) 247-254.
37. P. Libby, G. Sukhova, R.T. Lee, Z.S. Galis, Cytokines regulate vascular functions related to the stability of the atherosclerotic plaque, J. Cardiovascular Pharmacol. 25 (1995) S9-S12.
38. M. Kirstein, J. Brett, S. Radoff, S. Ogawa, D. Stern, H. Vlassara, Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of PDGF: role in vascular disease of diabetes and aging, Proc. Natl. Acad. Sci. USA 87 (1990) 9010-9014.
39. 2-microglobulin modified with advanced glycation endproducts in the pathogenesis of hemodialysis-assisted amyloidosis, J. Clin. Invest. 93 (1994) 521-528.
40. A.M. Schmidt, S.D. Yan, J. Brett, R. Mora, R. Nowygrod, D. Stern, Regulation of human mononuclear phagocyte migration by cell-surface binding-proteins for advanced glycation end- products, Diabetes 42 (1993) 1606-1613.
41. K. Takata, H. Seikoh, N. Araki, M. Shiga, M. Saitoh, Y. Morino, Scavenger receptor of human monocytic leukemia cell line (THP-1) and murine macrophages for nonenzymatically glycosylated proteins, Biochim. Biophys. Acta 986 (1989) 18-26.
42. N. Araki, T. Higashi, T. Mori, R. Shibayama, Y. Kawabe, T. Kodama, K. Takahashi, M. Shichiri, S. Horiuchi, Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end-products of the Maillard reaction, Eur. J. Biochem. 230 (1995) 408-415.
43. F. Hayase, Y. Konishi, H. Kato, Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate, Biosci. Biotech. Biochem. 59 (1995) 1407-1411.
44. M. Shinohara, I. Giardino, M. Brownlee, Overexpression of glyoxalase I inhibits intracellular advanced glycation endproduct (AGE) formation, Diabetes (Abstract) 45 (1996) 126A.
45. D.V. Zyzak, J.M. Richardson, S.R. Thorpe, J.W. Baynes, Formation of reactive intermediates from Amadori compounds under physiological conditions, Arch. Biochem. Biophys. 316 (1995) 547-554.
46. N. Shaklai, R.L. Garlick, H.F. Bunn, Nonenzymatic glycosylation of human serum albumin alters its conformation and function, J. Biol. Chem. 259 (1984) 3812-3817.
47. G. Hasegawa, K. Nakano, M. Kondo, Role of TNF and IL-1 in the development of diabetic nephropathy, Nefrologia 15 (1995) 1-4.
48. G.A. Limb, O. Earley, S.E. Jones, F. Leroy, A.M. Chignell, D.C. Dumonde, Expression of messenger RNA coding for TNF-α, IL-1β and IL-6 by cells infiltrating retinal membranes, Graeffes Arch. Clin. Exp. Ophthalmol. 232 (1994) 646-651.
49. G.J. Jaffe, W.L. Roberts, H.L. Wong, A.D. Yurochko, G.J. Cianciolo, Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells, Exp. Eye Res. 60 (1995) 533-543.
50. M.F. Lopes-Virella, G. Virella, Cytokines, modified lipoproteins and arteriosclerosis in diabetes, Diabetes 45 (1996) S40-S44.
51. A.D. Mooradian, R.L. Reed, K.E. Meredith, P. Scuderi, Serum levels of tumour necrosis factor and IL-1α and IL-β in diabetic patients, Diabetes Care 14 (1991) 63-65.
52. M.G. Cavallo, P. Pozzilli, C. Bird, M. Wadhwa, A. Meager, N. Visalli, A.J.H. Gearing, D. Andreani, R. Thorpe, Cytokines in sera from insulin-dependent diabetic patients at diagnosis, Clin. Exp. Immunol. 86 (1991) 256-259.